MCAP — MedCap AB (publ) Cashflow Statement
0.000.00%
- SEK6.86bn
- SEK6.98bn
- SEK2.11bn
Annual cashflow statement for MedCap AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 127 | 171 | 228 | 272 | 303 |
| Depreciation | |||||
| Non-Cash Items | 1 | -1.7 | 1 | -27.4 | -25.7 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -87.2 | -172 | -105 | -0.3 | -87.8 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 116 | 85.5 | 228 | 360 | 343 |
| Capital Expenditures | -60.9 | -44.3 | -39.3 | -66.2 | -62.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.9 | -11.8 | -113 | -62.6 | -329 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -64.8 | -56.1 | -152 | -129 | -391 |
| Financing Cash Flow Items | -0.1 | -7.3 | 0 | — | 0.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -64.1 | 61.2 | -120 | -46.1 | 52.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.9 | 96.5 | -48.1 | 182 | 0.2 |